ArticleCPT: pharmacometrics & systems pharmacology2026

Model-Informed Dosing Regimen of Sugemalimab for European Patients With Non-Small Cell Lung Cancer: Bridging From Asian Clinical Data.

Yucheng Sheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.